HN
Hutson Nancy J Director
Board F
US US · SEC (Form 4)
€52,616
▲ Purchases (5 ops.)
Explore the full record of transactions filed by Hutson Nancy J, Director. Officer active across 5 companies, notably Biocryst Pharmaceuticals INC. Cumulatively, 18 filings have been recorded. Total volume traded: €53k. The latest transaction was filed on 7 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations 18 total
012,866 shares 0
Common Stock
SEC:0001127602-22-017163:0 · 7 Jun 2022
€7,895 3,000 shares @ €2.6317 6.5% of flow
Common Stock
SEC:0001169245-22-000067:0 · 18 Aug 2021
Ideal exit: 15 May 2022 (T+270) €48,621 24,860 shares @ €1.9558 86.0% of flow
Common Stock
SEC:0001169245-21-000106 · 5 Nov 2021
€48,621 24,860 shares @ €1.9558 40.2% of flow
Common Stock
SEC:0001169245-21-000106:0 · 5 Nov 2021
€42,795 25,000 shares @ €1.7118 0.059% mcap 74.7% of flow
Common Stock
SEC:0001209191-21-062427 · 29 Oct 2021
€42,795 25,000 shares @ €1.7118 0.059% mcap 37.4% of flow
Common Stock
SEC:0001209191-21-062427:0 · 29 Oct 2021
€75,314 30,000 shares @ €2.5105 0.0045% mcap 76.1% of flow
Common Stock
SEC:0001127602-21-027342 · 15 Oct 2021
€75,314 30,000 shares @ €2.5105 0.0045% mcap 38.1% of flow
Common Stock
SEC:0001127602-21-027342:0 · 15 Oct 2021
€7,895 3,000 shares @ €2.6317 14.0% of flow
Common Stock
SEC:0001169245-21-000083 · 18 Aug 2021
Ideal exit: 15 May 2022 (T+270) €7,895 3,000 shares @ €2.6317 6.5% of flow
Common Stock
SEC:0001169245-21-000083:0 · 18 Aug 2021
Ideal exit: 15 May 2022 (T+270) €14,465 3,000 shares @ €4.8218 0.020% mcap 25.3% of flow
Common Stock
SEC:0001209191-21-051883 · 16 Aug 2021
Ideal exit: 13 May 2022 (T+270) €14,465 3,000 shares @ €4.8218 0.020% mcap 12.6% of flow
Common Stock
SEC:0001209191-21-051883:0 · 16 Aug 2021
Ideal exit: 13 May 2022 (T+270) 047,924 shares 0
Ordinary Shares
SEC:0001593034-21-000079 · 11 Jun 2021
047,924 shares 0
Ordinary Shares
SEC:0001593034-21-000079:0 · 11 Jun 2021
€19,510 8,333 shares @ €2.3413 0.0012% mcap 19.7% of flow
Common Stock
SEC:0001127602-21-019792 · 10 Jun 2021
€19,510 8,333 shares @ €2.3413 0.0012% mcap 9.9% of flow
Common Stock
SEC:0001127602-21-019792:0 · 10 Jun 2021
€4,100 317 shares @ €12.9335 0.0002% mcap 4.1% of flow
Common Stock
SEC:0001127602-21-018492 · 28 May 2021
€4,100 317 shares @ €12.9335 0.0002% mcap 2.1% of flow
Common Stock
SEC:0001127602-21-018492:0 · 28 May 2021
About Hutson Nancy J Nancy J Hutson is associated with BIOCRYST PHARMACEUTICALS INC.